Anixa Biosciences, Inc.
ANIX
$3.38
-$0.17-4.79%
NASDAQ
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.68M | 1.83M | 1.69M | 1.67M | 1.82M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.00M | 3.39M | 3.16M | 3.59M | 3.47M |
| Operating Income | -3.00M | -3.39M | -3.16M | -3.59M | -3.47M |
| Income Before Tax | -2.81M | -3.21M | -2.91M | -3.32M | -3.18M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.81M | -3.21M | -2.91M | -3.32M | -3.18M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 23.00K | 29.00K | 30.00K | 38.00K | 41.00K |
| Net Income | -2.79M | -3.18M | -2.88M | -3.28M | -3.14M |
| EBIT | -3.00M | -3.39M | -3.16M | -3.59M | -3.47M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.09 | -0.10 | -0.09 | -0.10 | -0.10 |
| Normalized Basic EPS | -0.05 | -0.06 | -0.06 | -0.06 | -0.06 |
| EPS Diluted | -0.09 | -0.10 | -0.09 | -0.10 | -0.10 |
| Normalized Diluted EPS | -0.05 | -0.06 | -0.06 | -0.06 | -0.06 |
| Average Basic Shares Outstanding | 32.20M | 32.20M | 32.18M | 32.05M | 31.91M |
| Average Diluted Shares Outstanding | 32.20M | 32.20M | 32.18M | 32.05M | 31.91M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |